Brief: Portage Biotech Announces Clinical Trial Collaboration Agreement With Merck
08/11/2022 13:58
Nov 8 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES CLINICAL TRIAL COLLABORATION
AGREEMENT
WITH MERCK
* PORTAGE BIOTECH ANNOUNCES CLINICAL TRIAL COLLABORATION
AGREEMENT
WITH MERCK
* PORTAGE BIOTECH INC- MERCK WILL BE PROVIDING KEYTRUDA FOR
PORTAGE BIOTECH'S IMPORT-201 TRIAL
Source text for Eikon: ID:nGNX5Shby5
Further company coverage: PRTG.O
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview